English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Nov 6, 2025

ACAAI foundation grants highlight new approaches to overcoming barriers in allergy care
Patient Daily | Nov 5, 2025

Pacific Research Institute CEO on misuse of 340B funds: ‘340B was meant to help low-income patients'
Patient Daily | Nov 5, 2025

Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’
+ Regulatory
Patient Daily | Nov 5, 2025

Bliksem Health founder: 'The 340B drug program was supposed to help poor patients'
+ Regulatory
Patient Daily | Nov 5, 2025

Pacific Research Institute CEO on 340B program: 'Providers are increasingly abusing 340B'
+ Pharmaceuticals
Patient Daily | Nov 5, 2025

Baylor researchers find some p53 mutations may improve responses to immunotherapy
Patient Daily | Nov 4, 2025

Philadelphia-based cardiologist: '340b is an absolute disaster that does next to nothing to help poor patients'
+ Pharmaceuticals
Patient Daily | Nov 4, 2025

American Lung Association urges action on biomarker test coverage in new Virginia report

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns